Spots Global Cancer Trial Database for recurrent gliosarcoma
Every month we try and update this database with for recurrent gliosarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma | NCT05017610 | Recurrent Gliob... Recurrent Glios... | Liothyronine Lomustine Methimazole | 18 Years - | Emory University | |
| Engineered NK Cells Containing Deleted TGF-BetaR2 and NR3C1 for the Treatment of Recurrent Glioblastoma | NCT04991870 | Recurrent Glios... Recurrent Supra... Supratentorial ... | Cord Blood-deri... Resection | 18 Years - | M.D. Anderson Cancer Center | |
| Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme | NCT00883298 | Recurrent Gliob... Recurrent Glios... | temozolomide an... | 18 Years - 83 Years | Center for Neurosciences, Tucson | |
| Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma | NCT05039281 | Recurrent Gliob... Recurrent Glios... | Atezolizumab Cabozantinib | 18 Years - | M.D. Anderson Cancer Center | |
| Lonafarnib and Temozolomide in Treating Patients With Glioblastoma Multiforme That Is Recurrent or Did Not Respond to Previous Treatment With Temozolomide | NCT00102648 | Malignant Supra... Recurrent Gliob... Recurrent Glios... | Lonafarnib Temozolomide | 18 Years - | M.D. Anderson Cancer Center | |
| Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma | NCT05465954 | High Grade Astr... Recurrent Gliob... Recurrent Glios... | Biospecimen Col... Efineptakin alf... Pembrolizumab | 18 Years - | Mayo Clinic | |
| Vaccine Therapy in Treating Patients With Recurrent Glioblastoma | NCT03360708 | Giant Cell Glio... Recurrent Gliob... Recurrent Glios... | Laboratory Biom... Malignant Gliom... | 18 Years - | Mayo Clinic | |
| Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas | NCT02192359 | Recurrent Anapl... Recurrent Anapl... Recurrent Anapl... Recurrent Gliob... Recurrent Glios... Recurrent Malig... Recurrent WHO G... | Carboxylesteras... Irinotecan Irinotecan Hydr... Laboratory Biom... Pharmacological... | 18 Years - 69 Years | City of Hope Medical Center | |
| Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM | NCT03283631 | Recurrent Gliob... Recurrent Glios... | EGFRvIII-CARs | 18 Years - | Duke University | |
| Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma | NCT05039281 | Recurrent Gliob... Recurrent Glios... | Atezolizumab Cabozantinib | 18 Years - | M.D. Anderson Cancer Center | |
| Vaccine Therapy in Treating Patients With Recurrent Glioblastoma | NCT03360708 | Giant Cell Glio... Recurrent Gliob... Recurrent Glios... | Laboratory Biom... Malignant Gliom... | 18 Years - | Mayo Clinic | |
| Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme | NCT00883298 | Recurrent Gliob... Recurrent Glios... | temozolomide an... | 18 Years - 83 Years | Center for Neurosciences, Tucson | |
| Multiple Doses of Neural Stem Cell Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas | NCT05139056 | Recurrent Anapl... Recurrent Anapl... Recurrent Anapl... Recurrent Gliob... Recurrent Glios... Recurrent Malig... Recurrent WHO G... Recurrent WHO G... | Neural Stem Cel... Resection | 18 Years - | City of Hope Medical Center | |
| Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma | NCT05039281 | Recurrent Gliob... Recurrent Glios... | Atezolizumab Cabozantinib | 18 Years - | M.D. Anderson Cancer Center | |
| Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma | NCT04477200 | Recurrent Gliob... Recurrent Glios... Recurrent Astro... Newly Diagnosed... Newly Diagnosed... Newly Diagnosed... | Mycophenolate M... Radiation Thera... Re-resection (a... Temozolomide Mycophenolate M... Mycophenolate M... Radiation Thera... | 18 Years - | University of Michigan Rogel Cancer Center | |
| Vaccine Therapy in Treating Patients With Recurrent Glioblastoma | NCT03360708 | Giant Cell Glio... Recurrent Gliob... Recurrent Glios... | Laboratory Biom... Malignant Gliom... | 18 Years - | Mayo Clinic |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
